Current Oncology Reports

Article	Citations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	133
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	127
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	87
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	85
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	80
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	77
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	71
New Developments in VHL-Associated Neuroendocrine Neoplasms	68
Management of Upper Tract Urothelial Carcinoma	65
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	51
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	51
Treatment of Metastatic Melanoma in the Elderly	49
Fatty Acid Metabolism and Cancer Immunotherapy	48
Brain Prehabilitation for Oncologic Surgery	41
Prostate Cancer Immunotherapy—Finally in From the Cold?	41
Surgical Management of Melanoma: Advances and Updates	40
Immunotherapy in Biliary Tract Cancers: Where Are We?	35
Current Trends and Challenges of Microbiome Research in Prostate Cancer	34
NRG1 Fusions: The New Kid on the Block	34
Management of In-Transit Metastases	34
New Insights on Tramadol and Immunomodulation	34
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	33
An Overview of Angiogenesis in Bladder Cancer	32
Engineered T Cells: CAR T Cell Therapy and Beyond	32
AXL Inhibitors: Status of Clinical Development	32

Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	31
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	31
Head and Neck Mucosal Melanoma: Where Are We Now?	31
Cellular Therapy in NSCLC: Between Myth and Reality	30
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	29
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	29
The Microbiome in Advanced Melanoma: Where Are We Now?	28
Anti-PD-1: When to Stop Treatment	28
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	28
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	27
The Difficult Airway in Patients with Cancer	27
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?	26
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review	25
Investigating the Latest Evidence from Phase III Trials Supporting Treatment Options for De novo Clinically Lymph Node-Positive Hormone-Sensitive Prostate Cancer	25
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?	25
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy	24
Cancer Pain Management—New Therapies	24
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors	23
Proton Therapy in The Treatment of Head And Neck Cancers- Review	23
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours	23
Appendiceal Neuroendocrine Neoplasms: an Update for 2023	23
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations	23
Geographical Disparities in Colorectal Cancer in Canada: A Review	22
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question	22
Targeting the PI3K Pathway in Gynecologic Malignancies	22
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations	22
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews	22
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases	22
CAR-T Therapies in Solid Tumors: Opportunities and Challenges	22
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	21
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer	21
Surgery for Recurrent Epithelial Ovarian Cancer	21
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma	21
Development of Effective Siglec-9 Antibodies Against Cancer	20
Helping Patients Understand and Cope with BRCA Mutations	20
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies	20
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review	20
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing	19
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer	19
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging	19
Current Management of Neuroendocrine Tumour Liver Metastases	19
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials	19
Vascular Inflammation, Cancer, and Cardiovascular Diseases	19
Evolving Treatment Approaches to Mucosal Melanoma	19
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions	19
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions	18
Elderly Rectal Cancer: An Updated Review	18
Management of Peripheral T-cell Lymphomas and the Role of Transplant	18
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia	18
Small Cell and Other Rare Histologic Types of Cervical Cancer	17

Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets	17
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?	17
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction	17
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review	16
Mesenteric Fibrosis in Neuroendocrine Neoplasms: a Systematic Review of New Thoughts on Causation and Potential Treatments	16
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer	16
Intratumoral Immunotherapy: Is It Ready for Prime Time?	16
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review	16
Ependymoma: Evaluation and Management Updates	16
Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management	16
Current Diagnostic Tools for Breast Cancer-Related Lymphedema	16
Multimodality Therapies for Localized Prostate Cancer	16
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity	16
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic	16
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights	16
History of Leukemia, Revisited	15
Statins for Cardiac and Vascular Protection During and After Cancer Therapy	15
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities	15
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review	15
Current Status on Management of Primary Plasma Cell Leukemia	15
Epidemiology of Cancer in Older Adults: A Systematic Review	15
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers	14
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy	14
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma	14
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours	14
Richter’s Transformation	14
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	14
Return to Intended Oncological Therapy: State of the Art and Perspectives	14
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade	14
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy	14
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives	14
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge	14
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment	14
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development	13
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas	13
Approaches to Non-Muscle-Invasive Bladder Cancer	13
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies	13
Bystander effect of antibody–drug conjugates: fact or fiction?	13
The Role and Impact of Minimal Residual Disease in NSCLC	13
Racial Disparities in Breast Cancer: from Detection to Treatment	13
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions	13
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis	13
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?	13
Is Myelodysplasia a Consequence of Normal Aging?	12
CDK4/6 inhibitors: The Devil is in the Detail	12
Carbon Ion Radiotherapy in the Head and Neck Cancers Treatment and its Potential Role in Personalized Treatment Approach– A Review of the Current Knowledge	12
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer	12
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL	12
Interventional Strategies in Cancer-induced Cardiovascular Disease	12
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer	12
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations	12
PARP Inhibitors in the Neoadjuvant Setting; A Comprehensive Overview of the Rationale for their Use, Past and Ongoing Clinical Trials	12
Viral and Clinical Oncology of Head and Neck Cancers	12
Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches—Focus on EZH2-Targeted Drugs	12
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer	11
Cardio-Oncology in Childhood: State of the Art	11
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer	11
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway	11
Advances in Treatment of Waldenström Macroglobulinemia	11
CAR T-cell Therapy for Central Nervous System Lymphoma	11
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine	11
Clinicopathological Review of Micropapillary Urothelial Carcinoma	11
Lymphatic Interventions in the Cancer Patient	11
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan	11
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis	11
Navigating the Cancer Screening Decision for Patients with Dementia	11
Current Role of Functional Imaging in the Management of Lymphoma	11
Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review	11
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	11
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers	11
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment	10
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes	10
Surviving Burnout as an Oncologist	10
Patterns of Care and Treatment Outcomes Among Men Diagnosed with Prostate Cancer from Culturally and Linguistically Diverse Backgrounds: A Scoping Review	10
Integrative Geriatric Oncology: A Review of Current Practices	10
Cytokines in the Treatment of Melanoma	10
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer	10
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?	10
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism	10
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab	10

Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy	10
Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity	10